Contact About Find a doctor Careers The Alfred Foundation For staff

Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals.

Search or browse research publications by year, research area, publication type or keyword.

Clear filter

Publication Details

Risk and prognosis of bacteremia and fungemia among first-time kidney transplant recipients: a population-based cohort study

Skov Dalgaard L, NØrgaard M, Povlsen JV, Morrissey O, Jespersen B, Jensen-Fangel S, østergaard LJ, SchØnheyder HC, SØgaard OS

(2017), ACS Infect Dis, 49(4), 286-95

DOI: 10.1080/23744235.2016.1248483

Major health impact of accelerated aging in young HIV-infected individuals on antiretroviral therapy

Rajasuriar R, Chong ML, Ahmad Bashah NS, Abdul Aziz SA, Mcstea M, Lee ECY, Wong PL, Azwa I, Syed Omar SF, Lai PSM, Ponampalavanar S, Crowe SM, Lewin SR, Kamaruzzaman SB, Kamarulzaman A

(2017), AIDS, 31(10), 1393-1403

DOI: 10.1097/QAD.0000000000001475

Laboratory workflow analysis of culture of periprosthetic tissues in blood culture bottles

Peel TN, Sedarski JA, Dylla BL, Shannon SK, Amirahmadi F, Hughes JG, Cheng AC, Patel R

(2017), J Clin Microbiol, 55(9), 2817-26

DOI: 10.1128/JCM.00652-17

Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis

Chang CC, Kangethe R, Omarjee S, Hiramen K, Gosnell B, Sojane K, Moosa MS, Lewin SR, French MA, Ndung'u T

(2017), Open Forum Infect Dis, 4(2), ofx032

DOI: 10.1093/ofid/ofx032

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study

Boyd MA, Amin J, Mallon PW, Kumarasamy N, Lombaard J, Wood R, Chetchotisakd P, Phanuphak P, Mohapi L, Azwa I, Belloso WH, Molina JM, Hoy J, Moore CL, Emery S, Cooper DA; SECOND-LINE Study Group

(2017), Lancet HIV, 4(1), e13-20

DOI: 10.1016/S2352-3018(16)30189-8

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

Borges °H, Hoy J, Florence E, Sedlacek D, Stellbrink HJ, Uzdaviniene V, Tomazic J, Gargalianos-Kakolyris P, Schmid P, Orkin C, Pedersen C, Leen C, Pradier C, Mulcahy F, Ridolfo AL, Staub T, Maltez F, Weber R, Flamholc L, Kyselyova G, Lundgren JD, Mocroft A; for EuroSIDA

(2017), Clin Infect Dis, 64(1), 1413-21

DOI: 10.1093/cid/cix167

Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors

Cameron DR, Lin YH, Trouillet-Assant S, Tafani V, Kostoulias X, Mouhtouris E, Skinner N, Visvanathan K, Baines SL, Howden B, Monk IR, Laurent F, Stinear TP, Howden BP, Peleg AY

(2017), Clin Microbiol Infect, 23(10), 767-73

DOI: 10.1016/j.cmi.2017.03.027

Optimal periprosthetic tissue specimen number for diagnosis of prosthetic joint infection

Peel TN, Spelman T, Dylla BL, Hughes JG, Greenwood-Quaintance KE, Cheng AC, Mandrekar JN, Patel R

(2017), J Clin Microbiol, 55(1), 234-43

DOI: 10.1128/JCM.01914-16

Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia

Cornely OA, Leguay T, Maertens J, Vehreschild MJGT, Anagnostopoulos A, Castagnola C, Verga L, Rieger C, Kondakci M, Hârter G, Duarte RF, Allione B, Cordonnier C, Heussel CP, Morrissey CO, Agrawal SG, Donnelly JP, Bresnik M, Hawkins MJ, Garner W, Gàkbuget N; AmBiGuard Study Group

(2017), J Antimicrob Chemother, 72(8), 2359-67

DOI: 10.1093/jac/dkx133

Changing epidemiology of candidaemia in Australia

Chapman B, Slavin M, Marriott D, Halliday C, Kidd S, Arthur I, Bak N, Heath CH, Kennedy K, Morrissey CO, Sorrell TC, van Hal S, Keighley C, Goeman E, Underwood N, Hajkowicz K, Hofmeyr A, Leung M, Macesic N, Botes J, Blyth C, Cooley L, George CR, Kalukottege P, Kesson A, McMullan B, Baird R, Robson J, Korman TM, Pendle S, Weeks K, Liu E, Cheong E, Chen S; Australian and New Zealand Mycoses Interest Group

(2017), J Antimicrob Chemother, 72(4), 1103-8

DOI: 10.1093/jac/dkw422

The impact of changes in HIV management guidelines on time to treatment initiation in Australia

Puhr R, Petoumenos K, Youds D, Law MG, Templeton DJ; Australian HIV Observational Database (AHOD) study group

(2017), HIV Med, 18(9), 701-3

DOI: 10.1111/hiv.12504

High rates of potentially infectious exposures between immunocompromised patients and their companion animals: an unmet need for education. Gurry GA, Campion V, Premawardena C, Woolley I, Shortt J, Bowden DK, Kaplan Z, Dendle C

Gurry GA, Campion V, Premawardena C, Woolley I, Shortt J, Bowden DK, Kaplan Z, Dendle C

(2017), Intern Med J, 7(3), 333-5

DOI: 10.1111/imj.13361

Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.

Trevillyan JM, Gardiner EE, Andrews RK, Maisa A, Hearps AC, Al-Tamimi M, Crowe SM, Hoy JF

(2017), Platelets, 28(3), 301-4

DOI: 10.1080/09537104.2016.1237627

Simultaneous ATR-FTIR based determination of malaria parasitemia, glucose and urea in whole blood dried onto a glass slide.

Roy S, Perez-Guaita D, Andrew DW, Richards JS, McNaughton D, Heraud P, Wood BR

(2017), Anal Chem, 89(10), 5238-45

DOI: 10.1021/acs.analchem.6b04578

Integrase-resistant HIV in an antiretroviral-naive patient in Australia.

Rafiei N, Woolley I, Korman TM, Chibo D, Gooey M, McMahon JH

(2017), AIDS, 31(4), 598-600

DOI: 10.1097/QAD.0000000000001377

Comparing non-occupational post-exposure prophylaxis drug regimens for HIV: insights from a linked HIV surveillance system.